Holen Sie sich die Stockscreener-App
3.02
0.33%
0.01
Handel nachbörslich:
29.72
26.70
+884.11%
Finanzdaten der Relmada Therapeutics Inc-Aktie (RLMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
1.2592 | 1.3214 | 1.3634 | 1.2076 |
Operating Expenses
|
14.32%
22.99
|
26.83 | 22.69 | 26.03 | 28.15 |
| Operating Income/Loss |
14.32%
-22.99
|
-26.83 | -22.69 | -26.03 | -28.15 |
| Nonoperating Income/Loss |
30.31%
1.1597
|
1.6642 | 0.6906 | 0.7238 | 1.832 |
| Income/Loss From Continuing Operations Before Tax |
1,833%
-21.83
|
1.2592 | 1.3214 | -25.30 | -26.32 |
| Income/Loss From Continuing Operations After Tax |
13.26%
-21.83
|
-25.17 | -22.00 | -25.30 | -26.32 |
|
Net Income/Loss
|
13.26%
-21.83
|
-25.17 | -22.00 | -25.30 | -26.32 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
30.13
|
- | 30.10 | 30.10 | 30.10 |
| Diluted Average Shares |
30.13
|
- | 30.10 | 30.10 | 30.10 |
| Basic Earnings Per Share |
13.25%
-0.72
|
-0.83 | -0.73 | -0.84 | -0.87 |
| Diluted Earnings Per Share |
194.74%
-0.72
|
0.76 | -1.31 | -0.84 | -0.88 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):